Avastin withdrawal symptoms.
Citation: Expert Opinion on Pharmacotherapy. 13(3):293-8, 2012 Feb.PMID: 22263961Institution: Washington Cancer InstituteForm of publication: Journal ArticleMedline article type(s): Editorial | Research Support, Non-U.S. Gov'tSubject headings: *Angiogenesis Inhibitors/tu [Therapeutic Use] | *Antibodies, Monoclonal, Humanized/tu [Therapeutic Use] | *Antineoplastic Combined Chemotherapy Protocols/tu [Therapeutic Use] | *Breast Neoplasms/dt [Drug Therapy] | Angiogenesis Inhibitors/ae [Adverse Effects] | Animals | Antibodies, Monoclonal, Humanized/ae [Adverse Effects] | Antineoplastic Combined Chemotherapy Protocols/ae [Adverse Effects] | Breast Neoplasms/bs [Blood Supply] | Breast Neoplasms/mo [Mortality] | Breast Neoplasms/pa [Pathology] | Disease-Free Survival | Drug Approval | Evidence-Based Medicine | Female | Humans | Patient Selection | Quality of Life | Risk Assessment | Time Factors | Treatment OutcomeISSN:- 1465-6566
Item type | Current library | Collection | Call number | Status | Date due | Barcode |
---|---|---|---|---|---|---|
Journal Article | MedStar Authors Catalog | Article | Available | 22263961 |
English